Broad Institute
Delve Bio, Broad Clinical Labs Partner for Metagenomic Infectious Disease Sequencing
Through the partnership, Delve Bio will leverage Broad Clinical Labs' sequencing capability to accelerate the commercialization of its metagenomic assay.
Top Five Articles on 360Dx Last Week: Roche Sues Stanford, Foresight Dx; More
Last week, readers were most interested in a story about a Roche lawsuit claiming trade secrets related to cancer detection and genetic sequencing technology were stolen.
The assays can be used to detect influenza A and influenza B, distinguish between flu subtypes, and identify strains that are resistant to antiviral treatment.
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
Premium
Although leading labs have coalesced around the value of protocols for making sure updated variant calls get to patients, strategies still vary and practical challenges remain.
Quest, Broad Clinical Labs to Assess Genome Sequencing as First-Line Test for Developmental Delay
The partners aim to demonstrate that WGS can provide insights at least as clinically accurate as the conventional tests clinicians use to diagnose developmental delay.